Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2021
Recall of products manufactured at Monroe
Glenmark recalled products made at its Monroe, North Carolina facility after United States regulatory concerns about manufacturing practices. The episode was followed by further inspection findings and corrective-action work.
2019
Glenmark recalls Estradiol Vaginal inserts in the United States
Recall announced
Glenmark Pharmaceuticals recalled approximately 217,000 cartons of Estradiol Vaginal inserts in the United States due to a defective delivery system. Complaints included that the applicator plunger was difficult to push. The FDA report described the action as a voluntary Class II recall.
Glenmark Pharmaceuticals is recalling about 217,000 cartons of Estradiol Vaginal inserts in the United States because of a defective delivery system, including complaints that the applicator plunger was difficult to push. The FDA report describes it as a voluntary Class II recall.
Source excerpt
Drug maker Glenmark Pharmaceuticals is recalling close to 2.17 lakh cartons of Estradiol Vaginal inserts in the US market due to faulty delivery system, as per a report by the American health regulator.
The ongoing voluntary class II recall is on account of defective delivery system with "complaints for difficulty in pushing the plunger of the applicator", it added.